“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management

Immune checkpoint inhibitors have shown efficacy in the treatment of different cancers by stimulating the antitumoral activity of the patient’s immune system, representing a major breakthrough in the field of cancer therapy. Monoclonal antibodies including anti-cytotoxic T-lymphocyte–associated prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Sollena, Pietro, Cappilli, Simone, Federico, Francesco, Schinzari, Giovanni, Tortora, Giampaolo, Peris, Ketty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Melanoma – Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122307/
https://www.ncbi.nlm.nih.gov/pubmed/33759689
http://dx.doi.org/10.1080/21645515.2021.1889449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122307/
https://www.ncbi.nlm.nih.gov/pubmed/33759689
http://dx.doi.org/10.1080/21645515.2021.1889449

Ejemplares similares